Summa Health, Humana reach accountable care agreement

Summa Health System, based in Akron, Ohio, has entered into an accountable care agreement with Humana, reports Crain's Cleveland Business.

As part of the deal, reimbursements will be tied to Summa’s ability to keep this particular population of patients healthy, according to the article.

Read more below:

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.